These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2005-005185-36 AN OPEN-LABEL PHASE III, STUDY TO EVALUATE THE SAFETY OF THE COMBINATION (FENOFIBRATE / PRAVASTATIN 160-40 MG) DURING 24 WEEKS, IN HIGH VASCULAR RISK PATIENTS WITH COMBINED HYPERLIPIDEMIA 2007-06-05 due-trials
Reported results 2006-001514-33 A phase III, randomized, parallel group study to compare the therapeutic efficacy of SMB BUDESONIDE-SALMETEROL DPI capsule 300/25µg BID delivered by the AXAHALER® versus SERETIDE® DISKUS® 500/50µg (Fl... 2008-03-14 due-trials
Reported results 2006-006557-28 A phase III, four-armed, randomised, double blind, parallel study to compare the efficacy and safety in type 2 diabetic patients with combined hyperlipidemia of a 12-week administration of Fenofibrate... 2008-12-16 due-trials
Reported results 2008-004833-70 A phase III, randomized, parallel group, open study to compare the therapeutic efficacy and safety of SMB BUDESONIDE-SALMETEROL DPI capsule 150/25μg BID delivered by the AXAHALER® versus SYMBICORT® TU... 2009-08-06 due-trials
Reported results Terminated 2010-018454-13 A Phase III, Multicentre, Randomised, Placebo-Controlled, Double Blind Study of the Incidence of Recurring Pulmonary Exacerbations in Cystic Fibrosis Patients using Two Different Doses of Inhaled Nacy... 2015-10-15 due-trials
Completed, but no date, and reported results 2010-020794-16 A phase II, randomised, partially-blinded, cross over study to evaluate the systemic effect of two doses of the SMB BUDESONIDE-SALMETEROL DPI fixed-dose combination capsule (300/25 µg BID and 150/25 µ... bad-data
Reported results 2010-023510-32 A phase IV, randomised, double-blinded, placebo-controlled, parallel study to estimate the influence of vitamin D (D-CURE®) supplementation on the 25-hydroxyvitamin D serum concentration in patients a... 2011-07-22 due-trials
Reported results 2012-000575-17 A phase III, two-armed, randomised, double blind, parallel study to compare the efficacy and safety in high CHD-risk patients with mixed dyslipidaemia of a 12-week administration of a fixed dose combi... 2015-03-16 due-trials
Reported results 2012-003417-34 A phase IV, two-armed, randomised, cross-over study to compare the compliance of a once-a-month administration of vitamin D3 (D-CURE®) to a daily administration of a fixed-dose combination of vitamin ... 2014-02-17 due-trials
Reported results 2012-004917-14 A phase IV, randomised, double-blinded, parallel study to estimate the dose-response of vitamin D (D-CURE®) supplementation on the 25-hydroxyvitamin D serum concentration in patients with vitamin D de... 2013-05-03 due-trials
Reported results 2014-003779-48 A phase IV, randomised, cross-over study to estimate the influence of food on the 25-hydroxyvitamin D3 serum level after vitamin D3 (D-CURE®) supplementation. 2015-03-23 due-trials
Reported results 2016-003755-29 A phase IV, randomised, parallel study to compare a monthly administration of vitamin D3 (D-CURE®) to a daily administration of vitamin D3 (VISTA-D3®). 2017-03-13 due-trials
Reported results 2017-002668-42 A randomised, interventional, double blind, crossover, controlled study to assess the effect of the administration of paracetamol on tramadol adverse events. Рандомизирано, интервенционално, двой... 2018-02-14 due-trials
Reported results 2017-003330-91 A pharmacokinetic and pharmacodynamic, randomised, single dose, cross-over, partially blinded study to compare the systemic exposure and the efficacy of a fixed-dose combination of Budesonide-Salmeter... 2018-09-30 due-trials
Reported results 2019-000640-10 A phase II, randomised, double-blind, and parallel study to estimate the dose-response of vitamin D supplementation in chronic kidney disease patients with secondary hyperparathyroidism and vitamin D ... 2020-06-18 due-trials
Reported results 2019-001160-29 A single blind, placebo controlled, three period, chronic dosing (6 weeks), multicentre, exploratory study to evaluate the effects of Nacystelyn (20 mg BID and 40 mg BID) on Functional Respiratory Ima... 2020-08-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2019-002408-42 A Phase 3, Double Blind, Multicentric, Randomised, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of Itraconazole Dry Powder for Inhalation for the Prevention of Invasive Mou... 2022-06-28 bad-data
Reported results 2019-004095-19 A pharmacodynamic, randomised, single dose, cross-over study to compare the bronchodilator effect of a new formulation of Tiotropium DPI versus Spiriva® 18 μg Handihaler® 2020-10-21 due-trials
Exempt, with results 2020-003404-14 A comparative study to assess a fixed-dose combination of Budesonide-Salmeterol versus Serevent® Diskus® 50 μg + Pulmicort® Turbuhaler® 100 µg co-administrated in asthmatic children: single dose, cros... 2021-04-26 not-yet-due
Reported results 2020-005270-10 A randomized, partially blinded, parallel study to evaluate the effects of nacystelyn in combination with isotretinoin in the treatment of recalcitrant acne vulgaris. 2022-09-01 due-trials